Riluzole API is a glutamate release inhibitor used in the treatment of amyotrophic lateral sclerosis (ALS) to slow disease progression.

Riluzole API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.